Discover myeloid insights with a targeted RNA panel
Identify known and novel fusions, splice variants, expression levels, single nucleotide variants, insertions, and deletions with targeted NGS of 84 genes relevant for acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and myelodysplastic syndromes (MDS) research.
Detect more with Archer FUSIONPlex NGS Panels for RNA.
Learn how the FUSIONPlex Myeloid panel can identify key genomic alterations for your research.
Request a consultationSpecifications | |
---|---|
Targeted genes | 84 |
Genomic alterations | Fusions, splicing, exon-skipping, SNVs, indels, expression levels |
Input nucleic acid required* | ≥10 ng |
Recommended number of reads | 1.5 M |
Hands-on time | <3.5 hours |
Total library prep time | 1.5 days |
Platform compatibility | Illumina® and Ion Torrent™ |
Reagent format | Lyophilized or liquid† |
Supported sample types | Blood, bone marrow, fresh frozen, FFPE, BMMC, PBMC |
*Input mass requirements vary depending on type and quality. Unless the tumor cellularity and sample quality are high, 50 ng of FFPE-derived nucleic acid should be considered the minimum recommendation. If input is not limiting, 200 ng is recommended.
†Liquid reagents available for Illumina platform only.
Customize this NGS panel by adding any of our functionally-tested designs or create a new panel that fits your exact requirements with Assay Marketplace.
Talk with our technical sales team. Learn how the FUSIONPlex Myeloid panel can identify key genomic alterations for your research.
Request a consultationRUO23-2278_001